Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.

Collen D, Schetz J, de Cock F, Holmer E, Verstraete M.

Eur J Clin Invest. 1977 Feb;7(1):27-35.

PMID:
65284
3.

Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").

Sambrano JE, Jacobson LJ, Reeve EB, Manco-Johnson MJ, Hathaway WE.

J Clin Invest. 1986 Mar;77(3):887-93.

4.

Antithrombin III transfusion in patients with hepatic cirrhosis.

Schipper HG, ten Cate JW.

Br J Haematol. 1982 Sep;52(1):25-33.

PMID:
7115627
5.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

Jørgensen M, Petersen LC, Thorsen S.

J Lab Clin Med. 1984 Aug;104(2):245-56.

PMID:
6747440
6.

Antithrombin III: biodistribution in healthy volunteers.

Knot EA, de Jong E, ten Cate JW, Gie LK, van Royen EA.

Thromb Haemost. 1987 Dec 18;58(4):1008-11.

PMID:
3445222
7.

Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiency.

Tengborn L, Frohm B, Nilsson LE, Nilsson IM.

Scand J Clin Lab Invest. 1981 Sep;41(5):469-77.

PMID:
7031840
8.

Hereditary antithrombin III deficiency in an English family.

Scully MF, De Haas H, Chan P, Kakkar VV.

Br J Haematol. 1981 Feb;47(2):235-40.

PMID:
7470393
9.

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.

Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.

Blood. 1985 Feb;65(2):496-500.

10.

Antithrombin III deficiency: decreased synthesis of a biochemically normal molecule.

Ambruso DR, Leonard BD, Bies RD, Jacobson L, Hathaway WE, Reeve EB.

Blood. 1982 Jul;60(1):78-83.

11.
12.

Turnover study of heparin cofactor II in healthy man.

Sié P, Dupouy D, Pichon J, Boneu B.

Thromb Haemost. 1985 Oct 30;54(3):635-8.

PMID:
3841420
13.

Antithrombin III deficiency: a report of 14 cases belonging to three different kindreds.

Girolami A, Cappellato MG, Vicarioto M, Marafiotti F, Traverso R, Vergolani A, Boeri G.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(4):594-606.

PMID:
2414189
15.

Kinetics of elimination of antithrombin III concentrate in heparinized patients.

Marciniak E, Gockerman JP.

Br J Haematol. 1981 Aug;48(4):617-25.

PMID:
7272219
16.

Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'.

Koide T, Takahashi K, Odani S, Ono T, Sakuragawa N.

Thromb Res. 1983 Jul 15;31(2):319-28.

PMID:
6636046
17.

Metabolism of antithrombin III in cirrhosis and carcinoma of the liver.

Chan V, Lai CL, Chan TK.

Clin Sci (Lond). 1981 Jun;60(6):681-8.

PMID:
6265140
18.

Catabolism and distribution of functionally heterogeneous human antithrombin III.

Marciniak E, Romond EH.

J Lab Clin Med. 1987 Jan;109(1):89-96.

PMID:
3794520
19.

Effect of thrombin and endotoxin on the in vivo metabolism of antithrombin III (AT III) in dogs.

Tanaka H, Kobayashi N, Maekawa T.

Thromb Res. 1985 Nov 1;40(3):291-306.

PMID:
4082111
20.

Supplemental Content

Support Center